Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer

Go back to Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer
(NASDAQ: EWTX) Delayed: 39.44 +0.13 (0.33%)
Previous Close $39.31    52 Week High $ 
Open $39.49    52 Week Low $ 
Day High $40.44    P/E N/A 
Day Low $39.16    EPS $ 
Volume 164,015